Published by Benjamin Chiou on 28th January 2025
(Sharecast News) - Specialist drug discovery and development outfit ImmuPharma has said that it can't pinpoint a reason behind its share price more than quadrapling over the past month.
URL: http://www.digitallook.com/dl/news/story/34841995/...